vs
Side-by-side financial comparison of Adaptive Biotechnologies Corp (ADPT) and MID PENN BANCORP INC (MPB). Click either name above to swap in a different company.
Adaptive Biotechnologies Corp is the larger business by last-quarter revenue ($70.9M vs $62.0M, roughly 1.1× MID PENN BANCORP INC). MID PENN BANCORP INC runs the higher net margin — 31.4% vs 4.7%, a 26.6% gap on every dollar of revenue. On growth, Adaptive Biotechnologies Corp posted the faster year-over-year revenue change (35.1% vs 30.8%). Over the past eight quarters, Adaptive Biotechnologies Corp's revenue compounded faster (28.1% CAGR vs 21.1%).
ExpreS2ion Biotechnologies is a Danish biotechnology company specialised in the development of new vaccines and immunotherapy products based in Hørsholm, Denmark and listed on the Nasdaq First North Growth Market Sweden.
Commerce Bancorp was a Cherry Hill, New Jersey–based bank created in 1973. In 2007, it was purchased by Toronto-Dominion Bank, which merged Commerce into TD Banknorth, the latter of which was rebranded to TD Bank.
ADPT vs MPB — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $70.9M | $62.0M |
| Net Profit | $3.4M | $19.4M |
| Gross Margin | 73.6% | — |
| Operating Margin | -27.1% | 43.6% |
| Net Margin | 4.7% | 31.4% |
| Revenue YoY | 35.1% | 30.8% |
| Net Profit YoY | — | 47.0% |
| EPS (diluted) | — | $0.83 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $70.9M | — | ||
| Q4 25 | $71.7M | $62.0M | ||
| Q3 25 | $94.0M | $61.8M | ||
| Q2 25 | $58.9M | $54.3M | ||
| Q1 25 | $52.4M | $47.7M | ||
| Q4 24 | $47.5M | $47.4M | ||
| Q3 24 | $46.4M | $45.3M | ||
| Q2 24 | $43.2M | $44.1M |
| Q1 26 | $3.4M | — | ||
| Q4 25 | $-13.6M | $19.4M | ||
| Q3 25 | $9.5M | $18.3M | ||
| Q2 25 | $-25.6M | $4.8M | ||
| Q1 25 | $-29.9M | $13.7M | ||
| Q4 24 | $-33.7M | $13.2M | ||
| Q3 24 | $-32.1M | $12.3M | ||
| Q2 24 | $-46.2M | $11.8M |
| Q1 26 | 73.6% | — | ||
| Q4 25 | 74.6% | — | ||
| Q3 25 | 80.7% | — | ||
| Q2 25 | 69.4% | — | ||
| Q1 25 | 67.6% | — | ||
| Q4 24 | 62.0% | — | ||
| Q3 24 | 64.1% | — | ||
| Q2 24 | 55.3% | — |
| Q1 26 | -27.1% | — | ||
| Q4 25 | -17.8% | 43.6% | ||
| Q3 25 | 10.9% | 39.3% | ||
| Q2 25 | -42.5% | 7.9% | ||
| Q1 25 | -56.4% | 35.2% | ||
| Q4 24 | -71.3% | 34.1% | ||
| Q3 24 | -70.3% | 32.8% | ||
| Q2 24 | -109.6% | 32.4% |
| Q1 26 | 4.7% | — | ||
| Q4 25 | -18.9% | 31.4% | ||
| Q3 25 | 10.2% | 29.6% | ||
| Q2 25 | -43.5% | 8.8% | ||
| Q1 25 | -56.9% | 28.8% | ||
| Q4 24 | -71.0% | 27.9% | ||
| Q3 24 | -69.1% | 27.1% | ||
| Q2 24 | -107.0% | 26.7% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.08 | $0.83 | ||
| Q3 25 | $0.06 | $0.79 | ||
| Q2 25 | $-0.17 | $0.22 | ||
| Q1 25 | $-0.20 | $0.71 | ||
| Q4 24 | $-0.22 | $0.72 | ||
| Q3 24 | $-0.22 | $0.74 | ||
| Q2 24 | $-0.31 | $0.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $77.6M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $814.1M |
| Total Assets | $505.9M | $6.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $77.6M | — | ||
| Q4 25 | $70.5M | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | $43.2M | — | ||
| Q1 25 | $50.6M | — | ||
| Q4 24 | $47.9M | — | ||
| Q3 24 | $38.1M | — | ||
| Q2 24 | $59.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | $218.8M | $814.1M | ||
| Q3 25 | $204.4M | $796.3M | ||
| Q2 25 | $179.7M | $775.7M | ||
| Q1 25 | $190.4M | $667.9M | ||
| Q4 24 | $202.7M | $655.0M | ||
| Q3 24 | $223.8M | $573.1M | ||
| Q2 24 | $241.6M | $559.7M |
| Q1 26 | $505.9M | — | ||
| Q4 25 | $512.7M | $6.1B | ||
| Q3 25 | $490.6M | $6.3B | ||
| Q2 25 | $496.6M | $6.4B | ||
| Q1 25 | $510.9M | $5.5B | ||
| Q4 24 | $539.4M | $5.5B | ||
| Q3 24 | $558.5M | $5.5B | ||
| Q2 24 | $584.9M | $5.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $80.0M |
| Free Cash FlowOCF − Capex | — | $71.8M |
| FCF MarginFCF / Revenue | — | 115.8% |
| Capex IntensityCapex / Revenue | — | 13.3% |
| Cash ConversionOCF / Net Profit | — | 4.12× |
| TTM Free Cash FlowTrailing 4 quarters | — | $132.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $2.1M | $80.0M | ||
| Q3 25 | $-7.1M | $26.3M | ||
| Q2 25 | $-12.4M | $29.0M | ||
| Q1 25 | $-28.5M | $11.5M | ||
| Q4 24 | $-12.5M | $51.4M | ||
| Q3 24 | $-27.1M | $16.9M | ||
| Q2 24 | $-17.3M | $18.0M |
| Q1 26 | — | — | ||
| Q4 25 | $1.4M | $71.8M | ||
| Q3 25 | $-7.5M | $24.3M | ||
| Q2 25 | $-13.1M | $27.2M | ||
| Q1 25 | $-29.7M | $8.8M | ||
| Q4 24 | $-12.6M | $44.5M | ||
| Q3 24 | $-27.4M | $16.8M | ||
| Q2 24 | $-19.0M | $17.7M |
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | 115.8% | ||
| Q3 25 | -8.0% | 39.4% | ||
| Q2 25 | -22.2% | 50.1% | ||
| Q1 25 | -56.7% | 18.4% | ||
| Q4 24 | -26.5% | 93.8% | ||
| Q3 24 | -59.0% | 37.1% | ||
| Q2 24 | -44.1% | 40.2% |
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | 13.3% | ||
| Q3 25 | 0.4% | 3.1% | ||
| Q2 25 | 1.1% | 3.2% | ||
| Q1 25 | 2.4% | 5.7% | ||
| Q4 24 | 0.2% | 14.6% | ||
| Q3 24 | 0.7% | 0.0% | ||
| Q2 24 | 4.0% | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.12× | ||
| Q3 25 | -0.75× | 1.44× | ||
| Q2 25 | — | 6.08× | ||
| Q1 25 | — | 0.84× | ||
| Q4 24 | — | 3.88× | ||
| Q3 24 | — | 1.37× | ||
| Q2 24 | — | 1.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
